Therapy areas

Menorrhagia

Assessing and managing women with heavy menstrual bleeding

The definition of heavy menstrual bleeding (HMB) has changed – it is no longer solely defined by millilitres of blood loss per cycle but now includes the impact on a women’s physical, social and emotional quality of life.1

>80%

of women say that HMB affects their relationship with their partner or their performance at work, and it affects attendance at school or work for 68% of sufferers.2

As many as 1 in 3 women are expected to be negatively affected by HMB during their life but knowledge of the condition is poor.2,3 As such, many women are unaware that there are treatment options available for HMB2 – you can help her to speak up with three key questions:

 

See how these same three questions can help you to determine individualised treatment plans for your patients through these case studies

Case studies

Once ‘bothersome bleeding’ has been identified, follow the HELP diagnostic pathway for HMB

*You may wish to consider other treatments after trial of pharmaceutical options as per NICE guidelines: NICE Heavy Menstrual Bleeding NG88, 2018.

 

The HELP protocol has been adapted in the UK to reflect the 2018 updated NICE guidelines. The HELP group is an expert panel of physicians from 12 countries with a special interest in heavy menstrual bleeding (HMB), supported by Bayer.

Download the interactive HELP treatment algorithm, including clinical considerations for all approved treatment options

 

Download

 

The HELP protocol has been adapted in the UK to reflect the 2018 updated NICE guidelines.

 

The HELP group is an expert panel of physicians from 12 countries with a special interest in heavy menstrual bleeding (HMB), supported by Bayer.

Bayer produces a number of materials to help women with HMB. Introduce your patients to HMB with ‘myheavyperiods.co.uk’; a patient website with information on identifying HMB, the causes and treatment options.

 

Visit here
myheavyperiods.co.uk

NICE recommends Mirena® as a first-line pharmaceutical treatment for HMB with no identified pathology.1

  • Provides effective relief from idiopathic menorrhagia.2
  • Achieves menstrual blood loss reduction of up to 96%.3
  • Reduced bleeding promotes the increase of blood haemoglobin levels.2
  • Improves quality of life more than usual medical treatments (tranexamic acid, mefenamic acid, combined oestrogen-progestogen or progesterone alone).4
  • Totally or occasionally absent menstruation has been associated with prolonged continuation with Mirena®.5
  • May effectively manage bleeding problems during the transition through menopause.6
MIrena levonorgestrel

Heavy Menstrual Bleeding (HMB): evidence-based learning for best practice.

A 30-minute, scientific e-learning course developed by the HELP expert panel of independent physicians*. Three case-based modules cover the diagnostic pathway and treatment algorithm for HMB to help you to counsel your patients effectively.

 

Start module

 

*The formation of the HELP expert panel and its ongoing work is supported by Bayer AG.

Gain real-world patient insights into heavy menstrual bleeding through these two short videos that can help both you and your patients relate to the condition.

Reporting adverse events and quality complaints

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc.

 

If you want to report an adverse event or quality complaint, reports can be directed to: Tel: 01182063500 or email: pvuk@bayer.com

 

Further information is available on the “contact” tab at www.bayer.co.uk.